Adam K. Stern - Jan 7, 2025 Form 4 Insider Report for DarioHealth Corp. (DRIO)

Role
Director
Signature
/s/ Adam Stern
Stock symbol
DRIO
Transactions as of
Jan 7, 2025
Transactions value $
$100,000
Form type
4
Date filed
1/10/2025, 04:04 PM
Previous filing
Aug 9, 2024
Next filing
Apr 10, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding DRIO Common Stock 194K Jan 7, 2025 Direct
holding DRIO Common Stock 123K Jan 7, 2025 AKS Family Partners L.P.
holding DRIO Series-C Preferred Stock 124K Jan 7, 2025 AKS Family Partners L.P.

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DRIO Series D-2 Preferred Stock Purchase $100K +100 $1,000.00 0 Jan 7, 2025 Common Stock $0.83 AKS Family Partners L.P. F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Series D-2 Preferred Stock will automatically convert into shares of common stock, subject to shareholder approval and certain beneficial ownership limitations, including a non-waivable 19.99% ownership blocker, on the 12-month anniversary of the issuance date. The Series D-2 Preferred Stock initially converts into shares of common stock at a conversion price of $0.83. In addition, the holders of Series D-2 Preferred Stock will also be entitled dividends payable as follows: ten percent (10%) of the number of shares of Common Stock issuable upon conversion of the Preferred Stock then held by such holder for each full quarter anniversary of holding for a total of four (4) quarters from the Closing Date, all issuable upon conversion of the Preferred Stock.